Centene Reports $71M Loss, Strong Medicaid Performance
Centene reported a net loss of $71 million in the third quarter, a significant improvement from the $6.63 billion loss in the same period last year. The company’s total revenue rose to $50.65 billion, surpassing analysts’ expectations. This marks a notable recovery, with revenue increasing from $49.69 billion in the third quarter of the previous year, as highlighted during the company’s earnings call.
Strong Performance Across Core Businesses
Centene’s core businesses, including Medicaid, Medicare, Medicare Advantage, and the Affordable Care Act marketplace, demonstrated solid performance. CEO Sarah London attributed the company’s progress to effective cost management and a focus on key areas like behavioral health, home health, and drug costs. London emphasized that these “solid underlying fundamentals” have accelerated the company’s earnings recovery beyond initial expectations. The ACA marketplace also outperformed during the quarter, further bolstering the company’s financial health.
Medicaid, a key segment, is “right on track”, according to London. Meanwhile, Medicare and Medicare Advantage are exceeding expectations, with break-even results projected for 2026 and better-than-break-even performance expected in 2027. This positive trajectory shows Centene’s strategic focus on these critical areas.
Legal Battle Over Star Ratings
Centene has joined other Medicare Advantage plans in suing the Centers for Medicare & Medicaid Services (CMS) over its star ratings system. The company argues that CMS violated statutory safeguards in implementing 17 measures, resulting in significant revenue losses. The lawsuit, filed on October 22 in federal court in Georgia, claims that these measures forced Centene to lose hundreds of millions of dollars in revenue, which could have been used to strengthen benefits, reduce premiums, and improve health outcomes.
This legal action follows a successful lawsuit by Clover, which led to the exclusion of the disputed measures from its 2027 star ratings. Centene estimates that it would receive approximately $448 million in increased 2028 quality bonus payments if the court rules in its favor. Centene wants the court to set aside its star ratings and declare that the company’s enterprise weighted average would be 4 stars.
Future Growth and Challenges
Looking ahead, Centene anticipates earnings growth in 2027, driven by tailored benefit plans in the ACA marketplace. The company expects these plans to better meet the needs of its members, enhancing both satisfaction and financial performance. However, the company faces challenges, including a 5% decline in Medicaid membership this quarter, as noted by CFO Drew Asher. Additionally, starting January 1, 2027, states will need to implement Medicaid work requirements, which could further impact membership numbers.
